Species differences in [11C]clorgyline binding in brain

Nuclear Medicine and Biology

Volumn 28, Issue 7, 2001, Pages 779-785

  Fowler, Joanna S ^a   Ding, Yu Shin ^a   Logan, Jean ^a   Macgregor, Robert R ^a   Shea, Colleen ^a   Garza, Victor ^a   Gimi, Raomond ^a   Volkow, Nora D ^a   Wang, Gene Jack ^a   Schlyer, David ^a   Ferrieri, Richard ^a   Gatley, S John ^a   Alexoff, David ^a   Carter, Pauline ^a   King, Payton ^a   Pappas, Naomi ^a   Arnett, Carroll D ^a  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

Baboon; Brain; Human; MAO A; PET; 11C clorgyline

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; CLORGYLINE; CLORGYLINE C 11; DEUTERIUM; TRACER; UNCLASSIFIED DRUG; AMINE OXIDASE (FLAVIN CONTAINING); CARBON; DIAGNOSTIC AGENT; DRUG DERIVATIVE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; MONOAMINE OXIDASE INHIBITOR; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; ARTICLE; BABOON; BRAIN; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BINDING; DRUG RETENTION; ENZYME INHIBITION; FEMALE; NONHUMAN; SPECIES DIFFERENCE; ANIMAL; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; ENZYMOLOGY; HUMAN; IMAGE PROCESSING; ISOTOPE LABELING; METABOLISM; PAPIO; SCINTISCANNING; SYNTHESIS;

ANIMALS; BRAIN; CARBON RADIOISOTOPES; CLORGYLINE; DEUTERIUM; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INDICATORS AND REAGENTS; ISOTOPE LABELING; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; PAPIO; RADIOPHARMACEUTICALS; SPECIES SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0034741134     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(01)00245-1     Document Type: Article

References (26)

1. Plasma input function determination for PET using a commercial laboratory robot
2. 11C]deprenyl
3. Deuterium isotope effects in relation to the chemical mechanism of monoamine oxidase
4. 11C-labeled MAO A inhibitors and their in vivo uptake kinetics in rhesus monkey brain
5. 11C-methyl]benztropine
6. 11C]Befloxatone, a novel highly potent radioligand for in vivo imaging monoamine oxidase A
7. Interactions of monoamine oxidase with substrates and inhibitors
8. 11C]clorgyline for measuring monoamine oxidase A (MAO A)
9. Evidence that L-deprenyl treatment for 1 week does not inhibit MAO A or the dopamine transporter in the human brain
10. 11C-labeled suicide inactivators and PET
11. Monoamine oxidase B (MAO B) inhibitor therapy in Parkinson's disease: The degree and reversibility of human brain MAO B inhibition by Ro 19 6327
12. Slow recovery of human brain MAO B after L-deprenyl withdrawal
13. 11C]L-deprenyl-D2 for MAO B mapping
14. 11C]L-deprenyl in living baboon brain
15. Brain monoamine oxidase A inhibition in cigarette smokers
16. 199 in human monoamine oxidase A and B do not determine substrate and inhibitor specificities as in rat
17. Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridinyl derivatives
18. Some observations upon a new inhibitor of monoamine oxidase in brain tissue
19. Some puzzling effects of monoamine oxidase inhibitors
20. Dramatic species differences in the susceptibility of monoamine oxidase B to a group of powerful inhibitors
21. 11C-methyl-L-methionine
22. 11C]methane
23. 11C]L-deprenyl in mice: Potential for the measurement of monoamine oxidase activity in brain using positron emission tomography
24. Synthesis of suicide inhibitors of monoamine oxidase: Carbon-11 labeled clorgyline, L-deprenyl and D-deprenyl
25. The structure of the covalent adduct formed by the interaction of 3-dimethylamino-1-propyne and the flavine of mitochondrial amine oxidase
26. 3H-Ro 196327 in vitro: Localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain